XVIVO — Xvivo Perfusion AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Xvivo Perfusion AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	160	354	399	246	546
Net Total Accounts Receivable
Net Total Receivables	48.6	43.5	59.6	99.8	111
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	260	463	548	468	826
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	23.6	21.3	26.3	47.6	97.6
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	634	1,150	1,543	1,733	2,196
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	52.6	72.2	105	135	134
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	57	142	257	303	251
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	578	1,008	1,285	1,430	1,945
Total Liabilities & Shareholders' Equity	634	1,150	1,543	1,733	2,196
Total Common Shares Outstanding